Roy E. Smith
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
-
- Systemic Sclerosis and Related Diseases
- Breast Lesions and Carcinomas
Papers in
- Co-authors
- Norman Wolmark (5 shared papers)Mirsada Begovič (2 shared papers)Linda H. Colangelo (5 shared papers)James J. Dignam (1 shared paper)Robert H. Oishi (1 shared paper)Maureen Kavanah (1 shared paper)Richard G. Margolese (1 shared paper)Louis Fehrenbacher (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)American Journal of Hematology (4 papers)Cancer (3 papers)Vehicle System Dynamics (2 papers)Blood (2 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Roy E. Smith
48 papers receiving 2.5k citations
Roy E. Smith's Hit Papers
Peers
Comparison fields: 5 of 114
- Cancer Research 630
- Pathology and Forensic Medicine 671
- Oncology 884
- Dermatology 230
- Otorhinolaryngology 107
Countries citing papers authored by Roy E. Smith
This map shows the geographic impact of Roy E. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy E. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy E. Smith more than expected).
Fields of papers citing papers by Roy E. Smith
This network shows the impact of papers produced by Roy E. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy E. Smith. The network helps show where Roy E. Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside Roy E. Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial Hit paper breakdown → | 1999 | 785 |
| 2 | 2006 | 248 | |
| 3 | 1999 | 214 | |
| 4 | 2007 | 190 | |
| 5 | 1989 | 165 | |
| 6 | 2005 | 127 | |
| 7 | 1992 | 112 | |
| 8 | 1998 | 90 | |
| 9 | 1986 | 83 | |
| 10 | 1984 | 76 | |
| 11 | 1998 | 70 | |
| 12 | 1983 | 64 | |
| 13 | A phase II trial of paclitaxel in squamous cell carcinoma of the head and neck with correlative laboratory studies. | 1995 | 55 |
| 14 | 2004 | 52 | |
| 15 | 2003 | 49 | |
| 16 | 2021 | 41 | |
| 17 | 1989 | 31 | |
| 18 | 2009 | 25 | |
| 19 | 1988 | 24 | |
| 20 | 1991 | 24 |
About Roy E. Smith
Roy E. Smith is a scholar working on Surgery, Oncology, Internal Medicine, Radiology, Nuclear Medicine and Imaging and Mechanical Engineering, having authored 56 papers that have together received 2.7k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (7 papers), Breast Cancer Treatment Studies (4 papers), Head and Neck Cancer Studies (4 papers), Soil Mechanics and Vehicle Dynamics (4 papers), Railway Engineering and Dynamics (4 papers), Neutropenia and Cancer Infections (3 papers), Cancer Treatment and Pharmacology (3 papers) and Health and Medical Research Impacts (2 papers). The work is most often cited by research in Cancer Research (630 citations), Pathology and Forensic Medicine (671 citations), Oncology (884 citations), Dermatology (230 citations) and Otorhinolaryngology (107 citations). Roy E. Smith has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Norman Wolmark, Mirsada Begovič, Linda H. Colangelo, James J. Dignam, Robert H. Oishi, Maureen Kavanah, Richard G. Margolese, Louis Fehrenbacher, E. Mamounas and Nikolay V. Dimitrov. Their work appears in journals such as Journal of Clinical Oncology, American Journal of Hematology, Cancer, Vehicle System Dynamics and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.